Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir/Sofosbuvir for HCV in Pediatric Gaucher Disease
NCT03721627Phase 4Unknown
- Sponsor
- Mansoura University Children Hospital
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ledipasvir and sofosbuvir in hepatitis C virus infection, sponsored by Mansoura University Children Hospital. Primary endpoint: Sustained Virologic Response at 18 months. Status: unknown.
02
Drugs
ledipasvirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT03721627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03721627.